BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25620614)

  • 1. Evaluation of urinary microRNA panel in bladder cancer diagnosis: relation to bilharziasis.
    Eissa S; Matboli M; Hegazy MG; Kotb YM; Essawy NO
    Transl Res; 2015 Jun; 165(6):731-9. PubMed ID: 25620614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
    Eissa S; Matboli M; Essawy NO; Kotb YM
    Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
    Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
    Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology.
    Yamada Y; Enokida H; Kojima S; Kawakami K; Chiyomaru T; Tatarano S; Yoshino H; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Cancer Sci; 2011 Mar; 102(3):522-9. PubMed ID: 21166959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
    El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W
    Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
    Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
    Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis.
    Eissa S; Habib H; Ali E; Kotb Y
    Med Oncol; 2015 Jan; 32(1):413. PubMed ID: 25511320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of miRNAs in urine samples of bladder cancer patients.
    Nekoohesh L; Modarressi MH; Mowla SJ; Sadroddiny E; Etemadian M; Afsharpad M; Zolfaghari F; Barzegari M; Saffari M; Oskooei VK; Motevaseli E; Ghafouri-Fard S
    Biomark Med; 2018 Dec; 12(12):1311-1321. PubMed ID: 30507304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.
    Wang J; Zhang X; Wang L; Dong Z; Du L; Yang Y; Guo Y; Wang C
    J Surg Oncol; 2015 Jun; 111(8):992-9. PubMed ID: 25975233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine carcinoembryonic antigen levels are more useful than serum levels for early detection of Bilharzial and non-Bilharzial urinary bladder carcinoma: observations of 43 Egyptian cases.
    Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
    World J Surg Oncol; 2007 Jan; 5():4. PubMed ID: 17224047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of a novel autophagy gene expression signature for human bladder cancer patients.
    Eissa S; Matboli M; Awad N; Kotb Y
    Tumour Biol; 2017 Apr; 39(4):1010428317698360. PubMed ID: 28381171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis.
    Eissa S; Matboli M; Mansour A; Mohamed S; Awad N; Kotb YM
    Med Oncol; 2014 Feb; 31(2):804. PubMed ID: 24375315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
    Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
    Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
    Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of a schistosoma haematobium specific microRNA as a predictive and prognostic tool for bilharzial bladder cancer in Egypt.
    Gaber DA; Wassef RM; El-Ayat WM; El-Moazen MI; Montasser KA; Swar SA; Amin HAA
    Sci Rep; 2020 Nov; 10(1):18844. PubMed ID: 33139749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
    Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
    J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
    Zuiverloon TC; Beukers W; van der Keur KA; Munoz JR; Bangma CH; Lingsma HF; Eijkemans MJ; Schouten JP; Zwarthoff EC
    BJU Int; 2012 Mar; 109(6):941-8. PubMed ID: 21756281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.